Attack Characteristics in Patients with Hereditary Angioedema Receiving Non-Androgen Long-term Prophylaxis

Lumry W, Baptist A, Soteres D, Manning M, Earl L, Connolly H, Audhya PK, Wang A, Andriotti T, Desai V
EAACI 2024

Treatment of HAE Attacks with Anticipated Future Oral On-Demand Therapies as Reported by Patients

Valerieva A, Jones D, van Kooten S, Malloy N, Heckmann M, Betschel S
EAACI 2024

Patient-Reported Benefits of Early On-Demand Treatment of HAE Attacks

Longhurst H, Guilarte M, van Kooten S, Malloy N, Heckmann M, Busse P
EAACI 2024

A sensitive and specific assay to characterize plasma kallikrein activity in plasma from hereditary angioedema patients

Lee D, Ghannam A, Murugesan N, Vincent D, Mogg A, Smith M, Hampton S, Feener E
EAACI 2024

Delayed On-demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated Barriers

Savic S, El-Shanawany T, Gurugama P, Jain R, Danese S, Ulloa J, Desai V, Audhya P, Yong P
EAACI 2024

Anxiety Associated with On-Demand Treatment for Hereditary Angioedema (HAE) Attacks

Yong P, El-Shanawany T, Gurugama P, Jain R, Danese S, Ulloa J, Desai V, Audhya P, Savic S
EAACI 2024

Unmet Needs Associated with Non-androgen Injectable Long-term Prophylaxis (LTP) Therapies for HAE

Lumry W, Baptist A, Soteres D, Manning M, Wynne-Cattanach K, Birija L, Audhya PK, Wang A, Andriotti T, Desai V
EAACI 2024

Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks

Riedl MA, Farkas H, Aygören-Pürsün E, Psarros F, Soteres DF, M.D., Staevska M, Cancian M
New England Journal of Medicine

Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema: Phase 3 KONFIDENT Trial Results

Cohn DM
EAACI 2024

Trends in Volume of On-demand Hereditary Angioedema Treatments in the US: A Retrospective Analysis of a Large Multi-payer Claims Database

Soteres DF, Maheshwari C, Sharma A, Wang A, Audhya PK, Tachdjian R
EAC 2024